Kyle Piskel is Chief Financial Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 154,578 shares of ADPT, which is worth approximately $820,809. The most recent transaction as insider was on May 15, 2024, when has been sold 31,260 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 155K
0% 3M change
76.53% 12M change
Total Value Held $820,809

KYLE PISKEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2024
BUY
Grant, award, or other acquisition
-
31,260 Added 16.82%
154,578 Common Stock
Mar 05 2024
SELL
Open market or private sale
$26,503 $3.43 p/Share
7,727 Reduced 5.9%
123,318 Common Stock
Mar 04 2024
BUY
Grant, award, or other acquisition
-
43,740 Added 25.03%
131,045 Common Stock
Nov 16 2023
SELL
Open market or private sale
$1,069 $4.13 p/Share
259 Reduced 0.3%
87,305 Common Stock
Mar 06 2023
SELL
Open market or private sale
$30,278 $8.58 p/Share
3,529 Reduced 3.87%
87,564 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
43,735 Added 32.44%
91,093 Common Stock
Nov 16 2022
SELL
Open market or private sale
$8,506 $8.87 p/Share
959 Reduced 2.01%
46,706 Common Stock
Mar 07 2022
SELL
Open market or private sale
$2,642 $12.01 p/Share
220 Reduced 0.46%
47,665 Common Stock
Mar 04 2022
BUY
Grant, award, or other acquisition
-
41,186 Added 46.24%
47,885 Common Stock
Nov 15 2021
BUY
Grant, award, or other acquisition
-
3,837 Added 36.42%
6,699 Common Stock
KP

Kyle Piskel

Chief Financial Officer
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT